Episode 100: From 23andMe to the Future of Personalized Genomics: Mike Polcari on Building the "Hugging Face of Multi-Omics"

What happens when the architect behind one of the world's largest consumer genomics platforms decides to build what comes next? In this episode of The DNA of Things, Dr. Jeremy Koenig sits down with Mike Polcari — former Chief Architect at 23andMe and now founder of Haplotype Labs — to talk about what the $100 genome actually unlocks, why genetics has been stuck in research labs for too long, and how a new infrastructure layer could finally bring polygenic risk scores into everyday clinical care.If you've ever wondered why your DNA report sits in a PDF collecting digital dust instead of actively guiding your health decisions in real time, this conversation is for you.Connect with Mike: https://www.haplotypelabs.com/contactKey Takeaways🧬 The genome is no longer expensive — interpretation is the bottleneck. Sequencing just crossed $100, but having data and knowing what to do with it are two very different things. Mike estimates we're still about five years from fully understanding an individual's germline genetics.🔬 Polygenic risk scores make genomics useful for everyone. Most people won't carry a dramatic single variant. PRS aggregates thousands of small signals to give meaningful risk predictions for things like heart disease and cancer — making DNA actionable for the masses, not just edge cases.🏗️ Haplo Hub eliminates the infrastructure tax. Building a genomics pipeline used to mean 18 months of engineering and millions spent before offering a single DNA insight. The Hub lets any lab or health brand go from raw data to validated risk scores via a clean API — no bioinformatics team required.🤖 AI chatbots can't replace validated genomic models. Ask ChatGPT for a PRS score and it'll confidently give you a wrong answer. Mike's vision is your omics data living in a secure, continuously updated cloud that health AI platforms can actually query accurately.📡 Your DNA should follow you — not stay locked with whoever sequenced you first. The personal omics cloud means your genome gets reinterpreted as science improves and integrates contextually into every health decision you make.🌐 Telehealth legitimization opened the market. COVID forced mainstream adoption of telehealth, creating national-scale infrastructure for preventative health services — exactly the kind that can finally incorporate genomics into care at scale.🔓 Open science needs a commercial on-ramp. Researchers publish better genomic models every month. Most never reach a clinic. Haplo Hub closes that 15-year translation gap. LINKS:https://www.drjeremykoenig.com/https://www.instagram.com/drjeremykoenig/https://www.youtube.com/@drjeremykoenigHere's the link for this week's episode: https://drjeremykoenig.substack.com/.